Biofrontera Inc.
BFRI
$1.54
-$0.02-1.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 46.18M | 43.20M | 41.71M | 37.17M | 39.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.18M | 43.20M | 41.71M | 37.17M | 39.19M |
| Cost of Revenue | 9.58M | 9.81M | 10.96M | 13.23M | 16.06M |
| Gross Profit | 36.60M | 33.39M | 30.74M | 23.94M | 23.13M |
| SG&A Expenses | 39.78M | 40.71M | 38.37M | 37.84M | 35.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.35M | 53.93M | 53.05M | 54.78M | 55.49M |
| Operating Income | -6.17M | -10.73M | -11.35M | -17.62M | -16.30M |
| Income Before Tax | -6.34M | -11.06M | -10.51M | -17.55M | -16.57M |
| Income Tax Expenses | 29.00K | 27.00K | 26.00K | 23.00K | 20.00K |
| Earnings from Continuing Operations | -6.37 | -11.09 | -10.54 | -17.57 | -16.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.37M | -11.09M | -10.54M | -17.57M | -16.59M |
| EBIT | -6.17M | -10.73M | -11.35M | -17.62M | -16.30M |
| EBITDA | -5.97M | -10.56M | -11.21M | -17.51M | -16.08M |
| EPS Basic | -0.59 | -1.11 | -1.18 | -1.84 | -2.21 |
| Normalized Basic EPS | -0.40 | -0.73 | -0.77 | -1.15 | -1.38 |
| EPS Diluted | -0.59 | -1.11 | -1.18 | -1.84 | -2.21 |
| Normalized Diluted EPS | -0.40 | -0.73 | -0.77 | -1.15 | -1.38 |
| Average Basic Shares Outstanding | 47.05M | 43.48M | 40.67M | 36.57M | 31.57M |
| Average Diluted Shares Outstanding | 47.05M | 43.48M | 40.67M | 36.57M | 31.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |